Yoram Alroy - SHL Telemedicine Insider

SHL Telemedicine Ltd -- USA Stock  

USD 7.52  0.00  0.00%

Founder and Pres

Mr. Yoram Alroy serves as President and NonExecutive Member of the Board of Directors at S H L Telemedicine Ltd since August 10, 2011. He was previously Chairman of the Board of Directors and President at the Company from September, 2003. He is the Founder of Shahal Medical Services Ltd., which later became S H L Telemedicine Ltd, and has served as the Company Chairman since its inception in 1987. Prior to founding S H L Telemedicine Ltd, Mr. Alroy had served as Executive Vice President and Member of the Executive Committee of IBM Israel for 18 years. After assignment at IBM Europe he was nominated to be a Member of IBM Israel Executive Committee. Mr. Alroy is also a Member of the Board of Trustees of the Ofek College for Engineering. Mr. Alroy is also a Director of the Board of Directors of Shahal Haifa, Shahal Rishon and SHL INT.
Age: 74  Founder Since 2011      
972 3 561 2212  http://www.shl-telemedicine.com

Management Efficiency

The company has return on total asset (ROA) of (11.66) % which means that it has lost $11.66 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (42.15) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 21.3 M in total debt with debt to equity ratio (D/E) of 54.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. SHL Telemedicine Ltd has Current Ratio of 1.23 suggesting that it may have difficulties to pay its financial obligations in time and when they become due.

Entity Summary

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine systems. SHL Telemedicine Ltd (SMDCY) is traded on OTC Market in USA. It is located in Tel Aviv, and employs 551 people.

Did you try this?

Run Price Exposure Probability Now
   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
Hide  View All  NextLaunch Price Exposure Probability
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add SHL Telemedicine Ltd to your portfolio

Top Management

SHL Telemedicine Leadership Team
Yoni Dagan, CTO, MBA
Ehud BenYair, CFO, CPA
Dvora Kimhi, Director
Uzi Blumensohn, Executive, MBA
Nehama Ronen, Director
Erez Nachtomy, EVP
Cailong Su, Director
Amnon Sorek, Director
Eli Alroy, Director
Martin Lehner, Managing Director
Elon Shalev, Chairman
Eran Antebi, CFO
Arie MD, Executive
Georg Oppen, Managing Director
Yehoshua Abramovich, Director
Nissim Zvili, Director
Yi He, Director
Ziv Carthy, Director, MBA
Doron Steiger, Director, MBA
Ronen Harel, Director
Yariv Alroy, CEO
Yoav Rubinstein, CEO
Xuequan Qian, Director
Erez Alroy, CEO, MBA
Amir Lerman, Director
Shenlu Xu, Director
Eyal Bakshi, Director
Xuewen Wu, Chairman
Arie Roth, Executive
Yossi Vadnagra, CFO
Yoram Alroy, Founder
Yuval Shaked, CEO, MBA
Eran Kristal, Executive, MBA
Irit Alroy, CTO

Stock Performance

SHL Telemedicine Performance Indicators